共 93 条
[1]
Estey E(2006)Acute myeloid leukaemia Lancet 368 1894-1907
[2]
Dohner H(2011)Therapeutic advances in acute myeloid leukemia J Clin Oncol 29 487-494
[3]
Burnett A(2004)Problems related to resistance to cytarabine in acute myeloid leukemia Leuk Lymphoma 45 1123-1132
[4]
Wetzler M(1991)Cytosine arabinoside in the treatment of acute myeloid leukemia: the role and place of high-dose regimens Ann Hematol 62 119-128
[5]
Lowenberg B(1998)Etoposide: four decades of development of a topoisomerase II inhibitor Eur J Cancer 34 1514-1521
[6]
Cros E(2005)The anthracycline antibiotics: antitumor drugs that alter chromatin structure Bioessays 27 50-56
[7]
Jordheim L(1997)Anthracyclines in haematology: preclinical studies, toxicity and delivery systems Blood Rev 11 201-223
[8]
Dumontet C(1993)Pharmacokinetics and metabolism of anthracyclines Cancer Surv 17 219-252
[9]
Galmarini CM(2011)Inverse relationship between leukaemic cell burden and plasma concentrations of daunorubicin in patients with acute myeloid leukaemia Br J Clin Pharmacol 71 514-521
[10]
Hiddemann W(1995)Clinical pharmacology of cytarabine in patients with acute myeloid leukemia: a cancer and leukemia group B study Cancer Chemother Pharmacol 36 425-430